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Abstract 
 
  
 Molecular chaperones are highly conserved, ubiquitous enzymes that maintain 
proteostasis by mediating protein structure in vivo. Post-translational modifications 
(PTMs) can act as a functional switch between chaperone pathways, allowing for cells to 
enact a coordinated response to cellular perturbations. Several PTMs are well-
characterized in the context of chaperone function, though the role of N-terminal 
acetylation is commonly overlooked, leading to an overwhelming lack of scientific 
understanding in this area of study. Ssa1, a Hsp70 class chaperone endogenous to 
Saccharomyces cerevisiae, is likely N-terminally acetylated, though in vitro studies of 
Ssa1 are limited by current purification methods which are resource-intensive. To address 
these limitations, we developed a one-step purification scheme that uses a Protein-A 
fusion transformant strain in combination with IgG-conjugated magnetic Dynabeads to 
facilitate Ssa1 pull-down.  Using this method, Ssa1 was natively isolated in high purity 
and yield while retaining its activity and our modification of interest. This study also 
established the basis for evaluating differences Ssa1 chaperone activity due to disruption 
of N-terminal acetylation by purifying Ssa1 in N-terminal acetylation deficient 
backgrounds. Through the expression and purification of the Ssa1 co-chaperone, Ydj1, 
this study has additionally provided components needed to facilitate future co-chaperone 
binding experiments, which will help determine the contribution of N-terminal 
acetylation to Hsp70 chaperone activity and efficiency.  
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 5 
Introduction 
 The majority of proteins expressed in cells must achieve a specific, highly defined 
three-dimensional structure, known as the native state, to execute proper enzymatic 
function (Petrescu et al. 2000; Klaips et al. 2018; Turoverov et al. 2010). The native state 
is dictated by the amino acid sequence of a given protein (Anfinsen, 1973), though now, 
the native state considered a designation of function rather than of structural character 
(Turoverov et al. 2010). The conceptual redefinition of native state is attributable to the 
discovery that several proteins retain their biological function while exhibiting notable 
structural disorder. Regardless of structural disorder, the majority of eukaryotic proteins 
require the assistance of chaperone proteins to assume their respective native 
conformations efficiently and within a biologically relevant timescale (Klaips et al. 
2018).  
Since their initial discovery, several families of chaperone proteins were 
identified across all domains of life, illustrating their highly conserved functional role in 
maintaining proteostasis. Molecular chaperones and their regulatory cofactors both 
mediate and coordinate the processes of protein synthesis, protein folding, 
conformational maintenance, and protein degradation (Klaips et al. 2018). In doing so, 
molecular chaperones prevent protein misfolding, aggregation, and the accumulation of 
toxic protein species (Kellner et al. 2014; Vjestica et al. 2013; Klaips et al. 2018) that is 
characteristic to several diseases linked to aberrant protein folding (Lee et al. 2013; 
Barral et al. 2004). Continued study indicates that post-translational modifications 
(PTMs) likely regulate alternative chaperone function (Griffith and Holmes, 2019). 
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Accordingly, the effects of PTMs on chaperone activity have become of increasing 
interest to both scientific and medical fields. 
 PTMs are known to be of critical importance to the efficiency of Hsp70 
chaperones. Hsp70 chaperones are the most evolutionarily conserved family of chaperone 
proteins, with the number of isoforms expressed increasing with organismal complexity 
(Gupta et al. 1993, Boorstein et al. 1994). Hsp70s exhibit extreme functional diversity 
and are able found to interact with a wide variety of client substrates within all major 
intracellular compartments (Gupta et al. 1993; Boorstein et al. 1994). Hsp70 expression  
was traditionally characterized as inducible because of their initial discovery under 
conditions of thermal stress, though it is now recognized that Hsp70s are also expressed 
constitutively (Lindquist and Craig, 1988).  
Organelle-associated Hsp70s are typically encoded by a single gene in the 
majority of organisms; conversely, cytoplasmic Hsp70s are usually encoded by a series 
of homologous genes. In Saccharomyces cerevisiae (yeast), there are at least fourteen 
identified Hsp70 isoforms, which are further categorized into five subclasses according to 
amino acid sequence identity conservation (Boorstein et al. 1994). Only two subclasses, 
Ssa and Ssb, exhibit a cytoplasmic distribution, with the expression of members of the 
Ssa subclass considered essential for cell viability (Boorstein et al. 1994) 
It is well established that Hsp70 chaperones are subject to several PTMs. PTMs 
modify the biochemical characteristic of specific amino acid side chains, resulting in the 
modified protein exhibiting both an altered form and dynamic, which serves to increase 
proteomic diversity (Truman et al. 2012; Morgner et al. 2015).To date the roles of several 
PTMs, including phosphorylation and lysine acetylation, have been characterized in the 
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context of Hsp70 activity; however, the role of N-terminal acetylation in Hsp70 
chaperone function remains comparatively limited (Griffith and Holmes, 2019).  
N-terminal acetylation is a PTM that leads to proteomic diversity through the 
constitution of a cellular acetylome, wherein N-terminally acetylated proteins exhibit an 
alternate function and dynamic, subsequently allowing cells to react specifically to 
environmental stressors or cellular perturbations by various intracellular signaling 
pathways. N-terminal acetylation is catalyzed by a collection of N-terminal 
acetyltransferases (NATs), which transfer acetyl moieties from acetyl-coenzyme A to a-
amino groups at specific N-terminal residues. One theoretical target of N-terminal 
acetylation is Ssa1, a member of the Ssa subclass of Hsp70 chaperones that are 
endogenous to S. cerevisiae. As an Hsp70 chaperone, Ssa1 works in tandem with its co-
chaperones, to maintain cellular proteostasis by restoring the native conformations of 
misfolded proteins via a transient, ATP-driven mechanism. 
There are several factors that implicitly hinder the study of Ssa1, though one of the 
most limiting factors is its purification. Purifying Ssa1 is often both a resource-intensive 
and time-consuming process, requiring expensive technologies and large starting volumes 
of culture to obtain a satisfactory yield. 
 To facilitate studies that further probe the functional and mechanistic changes 
associated with the N-terminal acetylation of Ssa1, we developed an efficient, user-
friendly, one-step purification method. Our method uses previously transformed strains 
expressing  Protein-A-tagged Ssa1 in combination with IgG-conjugated magnetic 
Dynabeads to facilitate pull-down without disrupting our modification of interest . Our 
results indicate that our method is able to natively isolate high yields of pure acetylated 
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and unacetylated Ssa1 without compromising enzymatic activity, allowing for future 
investigation of the effects of N-terminal acetylation on Hsp70 function and dynamic.  
 
Molecular Chaperones 
To maintain proteostasis, cells utilize the coordinated action of molecular 
chaperones to preserve the appropriate synthesis, folding, conformation, and degradation 
of target proteins (Jayark et al. 2020). The amino-acid sequence of any given protein, 
encoded in genomic DNA, dictates its native conformation. This fact exemplified by the 
ability of small proteins re-fold (within a microsecond timescale) without assistance 
when removed from denaturant in vitro (Hartl et al. 2011). This is a considerably more 
difficult feat for multi-domain proteins, which often requires several minutes to hours to 
achieve their respective native states, if even possible (Hartl et al. 2011). In vivo 
conditions further complicate protein folding due to macromolecular crowding within the 
cytosol, increasing the tendency of non-native and conformationally flexible proteins to 
aggregate (Hartl et al. 2011). By preventing aberrant intermolecular interactions and 
lowering entropic costs, chaperone proteins minimize protein aggregation, maintain 
protein solubility, and promote protein refolding (Griffith and Holmes, 2019).  
Chaperone proteins are best described as proteins that interact, stabilize, or assist 
a substrate protein in acquiring its native conformation without being present in its final 
structure (Hartl FU, 1996; Hartl et al. 2001).  Traditionally, chaperone proteins are 
categorized within families. Though structurally unrelated, members of chaperone 
families are often referred to as heat-shock proteins (Hsps) due to their induction under 
thermal stress and are classified according to molecular weight in kDa (Hartl et al. 2001). 
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sHsps  
Small heat shock proteins (sHsps) are a diverse chaperones chaperone family that 
is expressed in all domains of life (Liu et al. 2015; Jaya et al. 2009; Uji et al. 2019). The 
number of genes encoding sHsps increases with organismal complexity. Bacteria, 
Archaea, and unicellular eukaryotes usually possess one or two genes encoding sHsps, 
while multicellular eukaryotes may contain several, reaching 19 in Arabidopsis thaliana 
and 10 in humans (Żwirowski et al. 2017; Uji et al. 2019). Among the Hsps, the low-
molecular-weight sHsps (12-43-kDa) are the most strongly upregulated under stress 
conditions, when they may constitute >1% of the total cell protein concentration in 
certain cell populations (Liu et al. 2015; Rutsdottir et al. 2017; Uji et al. 2019). sHsps are 
known interact with a wide variety of substrates, and consequently have roles in several 
physiological processes including cell proliferation, cell differentiation, and cytoskeletal 
organization, among others (Giese et al. 2005; Uji et al. 2019). 
Generally, sHsps identify and bind to aggregation-prone, partially unfolded 
substrates, acting to stabilize and promote a refolding-competent state in an ATP-
independent manner (Liu et al. 2015, Giese et al. 2005; Cashikar et al. 2005; Uji et al. 
2019). While this is ongoing, ATP-driven chaperones, namely Hsp70 and Hsp100, will 
together rescue and restore the native conformation of the substrate initially bound by the 
sHsp (Liu et al. 2015, Giese et al. 2005; Cashikar et al. 2005; Uji et al. 2019; Żwirowski 
et al. 2017; Peschek et al. 2013). A striking feature of sHsps is assembly into oligomeric 
complexes, ranging from the inclusion of 12 to over 24 subunits (McLoughlin et al. 
2016). While oligomerized, sHsps preserve quaternary structure, which limits their ability 
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to interact with substrates (Liu et al. 2015; Poulain et al. 2010). Notably, the equilibrium 
between the oligomeric and smaller sHsps species shifts under increased temperatures, 
with sHsps assuming a dimeric formation that promotes binding of exposed hydrophobic 
patches belonging to partially misfolded proteins (Żwirowski et al. 2017).  
Monomeric sHsps contain a signature a-crystallin domain (ACD) that is bordered 
by a variable-length N-terminal region (NTR) and a short C-terminal region (CTR) 
(Rutsdottir et al. 2017; McLoughlin et al. 2016). The ACD is a conserved C-terminal 
domain that acts as supportive structure within the sHsp (Cashikar et al. 2005; Rutsdottir 
et al. 2017), while the CTR directly contributes to sHsps oligomerization by the presence 
one of the following conserved motifs, I-X-I, I/V-X-I, I-X-I/S, or I/V-X-I/V (Rutsdottir et 
al. 2017, Poulain et al. 2010). The N-terminal region (NTR), which facilitates substrate 
binding, often varies in composition between sHsps, likely contributing to differences in 
substrate specificity between different sHsps (Rutsdottir et al. 2017).  
 
Hsp90 
Hsp90s are both a highly conserved and ubiquitous chaperone family that exist in 
all living domains except Archaea (Johnson et al. 2009; Sullivan et al. 1997; Hoter et al. 
2018). Hsp90s can constitute £ 2% of mammalian proteins present under non-stress 
conditions (Johnson et al., 2009; Sullivan et al. 1997; Hoter et al. 2018), and it is known 
that the expression of at least one isoform is required for eukaryotic viability (Johnson et 
al. 2009). Hsp90 function is ATP-dependent, requiring the association of Hsp70, Hsp40, 
and other co-chaperones (Johnson et al. 2009; Prodromou et al. 1997). In eukaryotic 
cells, cytosolic Hsp90s interact with specific client proteins that are involved in several 
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cellular processes including signal transduction, cell cycle regulation, cell viability, cell 
differentiation, apoptosis, adaptive immunity, and hormone responsiveness (Prodromou 
et al. 1997; Hoter et al. 2018). The additional co-chaperones that may be affiliated with 
the Hsp90-70-40 complex are shown to be dependent on the identity of the client protein 
(Prodromou et al. 1997).   
Twelve Hsp90 co-chaperones are observed in S. cerevisiae, all of which are 
present as homologs in mammalian cells, though mammals have additional co-
chaperones that are not otherwise present in yeast (Johnson et al. 2009 While the specific 
functions of Hsp90 co-chaperones remain unknown, though their association to Hsp90 
can either be spontaneous or may require the binding of ATP to the Hsp90 NTD for 
successful association (Sullivan et al. 1997; Prodromou et al. 2000). Mutations of the 
Hsp90 N-terminus which prevent ATP binding are known to alter co-chaperone binding 
(Prodromou et al. 2000). 
The overall molecular structure of Hsp90 comprises three conserved domains, the 
ATPase N-terminal domain (NTD), the C-terminal domain (CTD), and the middle 
domain (MD) (Hoter et al. 2018). Eukaryotic Hsp90s also include a flexible charged 
linker domain (CR) between the NTD and MD, which was shown to be essential for 
chaperone function, client interaction, and conformational flexibility (Hoter et al. 2018).  
Under physiological conditions, Hsp90 typically exists as a homodimer, though 
when dimerized, Hsp90 assumes a molecular clamp conformation that allows for 
substrate interaction (Hoter et al. 2018). Hsp90 dimerization is regulated by the NTD and 
occurs by interaction of CTDs via conserved MEEVD or KDEL motifs, the presence of 
which are isoform and cellular localization dependent (Prodromou et al. 2000; Hoter et 
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al. 2017). Co-chaperone binding occurs in the NTD, MD, and CTD, though client protein 
binding occurs primarily in the MD and CTD (Hoter et al. 2018). When ATP is bound, 
Hsp90 exhibits a conformation that exhibits decreased substrate affinity by means of 
decreasing the overall hydrophobicity of the chaperone. Assuming this low-affinity 
conformation, Hsp90 is able to bind and stabilize client proteins in substantially folded 
states (Prodromou et al. 2000).  
 
Hsp100 
Hsp100 chaperones, or Clp proteins, belong to the AAA+ family of ATP-
dependent molecular chaperones (Zeymer et al. 2013; Krzewska et al. 2001). Generally, 
Hsp100s promote the disassembly of protein aggregates, though specific members can 
also convey cellular thermotolerance or act as subunits of ATP-dependent proteases 
(Krzewska et al. 2001). There are two classes of monomeric Hsp100s that are designated 
by the number of NBDs (nucleotide binding domains) present. Class I Hsp100 
chaperones have two NBDs, while class II chaperones contain a single NBD (Lee et al. 
2003; Xeymer et al. 2013). When not present in a monomeric state, Hsp100s typically 
oligomerize into hexameric ring complexes. 
Of the Hsp100s, Hsp104 is especially notable for its essential role in conveying 
thermotolerance in S. cerevisiae (Okuda et al. 2015). While there are prokaryotic 
homologs of Hsp104, such as ClpB in Escherichia coli, a mammalian equivalent has not 
been identified (Okuda et al. 2015; Vacher et al. 2005). When acting in cooperation with 
the Hsp70/40 chaperone system, Hsp104 solubilizes aggregates in a multistep fashion 
(Okuda et al. 2015). The protein aggregates are initially bound by an Hsp70/40 complex, 
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which then recruits Hsp104/ClpB (Okuda et al. 2015). Once recruited, Hsp104/ClpB uses 
the hydrolysis of ATP to thread the aggregate through the central pore of its hexameric 
ring, promoting reactivation and solubilization of the aggregates (Okuda et al. 2015; 
Weibezahn et al. 2004).  
 
Hsp70 
Hsp70 chaperones associate with client proteins during the early stages of the 
folding process (Jana et al. 2009). Hsp70s are capable of acting dynamically and may 
promiscuously associate to aberrantly folded substrates or preferentially binding to folded 
substrates (Laufen et al. 1999; Umehara et al. 2018; Rosenzweig et al. 2019). Hsp70s are 
the most evolutionarily conserved protein known and are expressed in all organisms 
(Daugaard et al. 2007). The conserved nature of Hsp70 is reflected structurally, as the 
prokaryotic Hsp70, DnaK, shares 50% amino acid identity with eukaryotic Hsp70s 
(Daugaard et al. 2007). Furthermore, Hsp70 exhibits extreme functional conservation, as 
demonstrated by its ability to complement chaperone action both in vitro (Jäättelä et al. 
1992; Li et al. 1990) and via its transgenic expression (Li et al. 1990; Pelham HR, 1984).     
Hsp70s have a universal structure comprised of a N-terminal 44-kDa ATPase 
nucleotide binding domain (NBD) and an 18-kDa C-terminal substrate-binding domain 
(SBD), which interacts with short hydrophobic regions of client proteins (Kellner et al. 
2014; Taneva et al. 2010; Lui et al. 2007; Mayer and Kityk, 2015; Sharma et al. 2009).  
The NBD contains four subdomains which are further separated into two lobes (I and II) 
by an intervening central ATP binding pocket. The SBD contains a two-layered b-
sandwich domain (SBDb) that surrounds the substrate binding site, an a-helical lid 
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domain (SBDa), which shields the SBD when the chaperone assumes a closed 
conformational state, and an intrinsically disordered region present at the extreme C-
terminus (C-IDR) (Gong et al. 2018; Zhang et al. 2014). Notably, the C-IDR contains an 
EEVD motif and a GGAP motif which promotes co-chaperone and substrate recognition, 
respectively (Gong et al. 2018; Zhang et al. 2014). Notably, the substrate diversity of 
Hsp70 is due to the degenerative recognition motif within the SBDb, which features an 
amino acid composition that is highly advantageous for client binding (Jaya et al. 2009; 
Rüdiger et al. 1997).  
The NBD and SBD domains are connected by a highly conserved interdomain 
linker, which is largely hydrophobic and  allosterically coordinates the respective 
domains, which is essential for Hsp70 function (Umehara et al. 2018; Zhang et al. 2014). 
Interdomain allosteric communication allows proper Hsp70 function via the cycling 
between two main conformations, as dictated  by the inherent ATPase activity of the 
chaperone (Jana et al. 2009). When ATP is bound within the NBD, Hsp70 assumes an 
open conformation which exhibits a low substrate affinity along with high rates of 
substrate association and dissociation (Rippmann et al. 1991; Shorter et al. 2008; Abrams 
et al. 2014; Mayer and Kityk, 2015). Conversely, ATP hydrolysis promotes a closed 
conformation, which displays a 100- and 1000-fold decrease in substrate on/off rates, 
respectively, and a 10- to 50-fold increase in substrate affinity (Rippmann et al. 1991; 
Abrams et al. 2014; Shorter et al. 2008; Mayer and Kityk, 2015). The reiteration of these 
two conformations ultimately result in the promotion of the substrate to its natural state 
(Abrams et al. 2014).  
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The regulatory mechanisms underlying Hsp70 allostery remain to be 
characterized, though the conformational cycling by which Hsp70 facilitates substrate 
refolding is regulated by nucleotide binding, substrate identity, Hsp40 co-chaperones, and 
nucleotide exchange factors (NEFs), respectively. Both the association of Hsp40s, which 
coordinate Hsp70 ATP-ase activity with substrate binding, and NEFs, including the 
members of the GrpE, Snl1 (Bag-1), Sse1/Sse2 (Hsp110), Fes1 (HspBp1) families, which 
expedite nucleotide exchange, greatly enhance chaperone efficiency (Abrams et al. 2014; 
Mayer and Kityk, 2015; Sharma et al. 2009; Ngosuwan et al. 2003).  
 
Hsp40s and NEFs 
When acting in concert with members of the Hsp70 family, Hsp40s target Hsp70s 
to specific substrates by modulating Hsp70 ATPase activity and stabilizing Hsp70-
polypeptide complexes (Vjestica et al. 2013; Lu and Cyr. 1998; Laufen et al. 1999). 
Hsp40 activity is essential for Hsp70 efficiency though the mechanism by which Hsp40 
chaperones target Hsp70s to substrates is not yet known (Fan et al. 2005).  Hsp40 
members exhibit unique combinations of four characteristic domains that were initially 
described in the prototypic DnaJ endogenous to Escherichia coli : the J-domain, a C-
terminal peptide fragment, a G/F-rich containing region, and a zinc finger-like domain 
(Lu and Cyr, 1998; Greene et al. 1998; Hu et al. 2008). Conservation across the four 
characteristic domains occurs only in a small selection of Hsp40s; therefore, Hsp40s are 
categorized into three subtypes according to their domain composition. Only Type I 
Hsp40s, including Ydj1 in S. cerevisiae and Hdj2 in humans, share all four canonical 
domains with DnaJ (Hu et al. 2008; Kityk et al. 2018; Cheetham et al. 1994; Cyr and 
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Douglas, 1994). Overall, the J-domain, a helical harpin structure (70-75 residues), is the 
most conserved of the Hsp40 domains (Kityk et al. 2018; Lu et al. 1998; Cheetham et al. 
1994; Wall et al. 1995). Additionally, the J-domain contains the signature HPD motif 
which is responsible interacting with Hsp70 and regulating the ATPase activity of Hsp70, 
modulating substrate binding (Fan et al. 2005; Misselwitz et al. 1998; Sha et al. 2000) 
 Conversely, NEFs, which bind to the Hsp70 NBD, hasten the process of 
nucleotide exchange (Abrams et al. 2014). Four families of NEFs are known to interact 
with Hsp70: GrpE, Sse1/Sse2 (Hsp110), Fes1 (HspBp1), and Snl1 (Bag-1); the last three 
have homologs present in humans (Abrams et al. 2014). Overall, each NEF family is  
structurally distinct and varies from one another in terms of general mechanism, 
interaction, and affinity for Hsp70 (Abrams et al. 2014; Sondermann et al. 2001).  
 
Molecular chaperones in disease and treatment   
 The medical relevance of protein folding is considerable. A number of human 
diseases, including the classic examples of Alzheimer’s disease (AD) and cystic fibrosis 
(CF), are now suggested to result from aberrant protein folding (Barral et al. 2004). 
While there are various mechanisms by which aberrant protein folding contributes to 
cellular dysfunction, it is evident that chaperone proteins play an increasingly direct role 
in protein-folding diseases. Consequently, the overall contribution of chaperone proteins 
to disease onset and their potential as therapeutic targets have become subjects of 
increased study.  
 To date, several inheritable diseases have been linked to mutations occurring in 
chaperone-encoding genes. There are too many examples to discuss extensively within 
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this body of work; however, this point is easily exemplified by the study of a-crystallins, 
a well-known sHsp (Barral et al. 2004; Jaya et al. 2009; Giese et al. 2005).  In humans, a-
crystallin is composed of two subunits, aA and aB, both encoded by separate genes 
(Barral et al. 2004). Missense mutations of a conserved arginine residue within the core 
domains of each subunit implicated in the onset of human disease.  The R120G in αB-
crystallin results desmin-related myopathy (DRMs) (Ojha et al. 2010; Treweek et al. 
2005), while the R116C mutation in aA-crystallin results in hereditary cataracts (Litt et 
al. 1998).  
aA-crystallin is a major cytosolic constituent of the lens within the eye. While it 
is not well understood how R116C aA-crystallin affects lens opacity, it is likely that the 
inability of aA-crystallin to promote the folding of other major lens proteins leads to the 
precipitation of b- and g-crystallin and subsequent cataract formation (Litt et al. 1998; 
Barral et al. 2004). Conversely, aB-crystallin interacts desmin protein within skeletal 
muscle cells and is suggested to promote either folding or intermediate filament assembly 
(Djabali et al. 1997; Barral et al. 2004).  
Hsp90 is also known to contribute to several pathologies, though most notably 
Parkinson’s disease (PD). PD is a neurodegenerative disorder that is characterized by 
bradykinesia, rigidity, resting tremors, the loss of dopaminergic neurons in the substantia 
nigra and the formation of Lewy bodies in patients (Wang et al. 2008). Some inherited 
cases of PD are the result of a toxic gain of function in leucine-rich repeat kinase 2 
(LRRK2), which normally complexes with Hsp90 (Wang et al. 2008). 
The importance of Hsp70 chaperones in disease is impossible to overlook (Barral 
et al. 2004), especially polyglutamate expansion diseases. To date, at least eight inherited 
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human neurodegenerative diseases are linked to polyglutamate expansion, including 
Parkinson’s disease, prion diseases, and Alzheimer’s disease (Magrane et al. 2004). 
Polyglutamine domain expansion promotes protein toxicity, dysfunction, and neuronal 
loss, promoting aggregation and formation of ubiquinated nuclear inclusions (NI) 
(Warrick et al. 1999). Though while chaperone proteins contribute to disease, it is 
increasingly apparent that Hsps are of notable importance in devising novel treatments. 
For example, on a Drosophila melanogaster model of polyglutamine disease, directed 
expression of Hsp70 suppressed polyglutamine-induced neurodegeneration in vivo, 
indicating that Hsp70 may provide a means of treatment (Warrick et al. 1999).  
Another example is found in the transgenic expression of Hsp27, which was 
determined to reduce cortical damage after cerebral ischemia through mediating cell 
death in mice (van der Weerd et al. 2009). Similarly, the use of Hsp90 inhibitors 
promotes the degradation of mutant LRRK2 by blocking the disassociation of Hsp90-
LRRK2, establishing a potential route of treatment for PD (Wang et al. 2008).  
Overall, it is clear that modulating chaperone function holds incredible 
therapeutic potential thought it is worthwhile to also consider the role of post-
translational modification (PTMs) in both disease pathology and altered chaperone 
function. PTMs occur in response to dynamic cellular conditions and are catalyzed by 
highly specialized enzymes. Several PTMs, including phosphorylation, methylation, and 
acetylation involve the covalent addition of small functional groups to target proteins at 
specific residues, though macromolecules, including carbohydrates and lipids, may also 
be used to modify target substrates.  
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It is well known that PTMs can act as a functional switch between different 
chaperone pathways by altering chaperone binding to both clients and co-chaperones; 
however, the role of N-terminal acetylation in chaperone function is commonly 
overlooked, leading to an overwhelming lack of scientific understanding in this area of 
study. 
 
N-terminal acetylation 
N-terminal acetylation is an irreversible protein modification in which an acetyl 
moiety is transferred from acetyl-coenzyme A (Ac-CoA) to the a-amino group of a 
polypeptide chain (Polevoda et al. 1999). N-terminal acetylation increases proteomic 
diversity by constituting an intracellular “acetylome,” wherein  N-terminally acetylated 
proteins exhibit altered function and provide the basis for cell signaling, allowing a given 
cell to react specifically to perturbation. The prevalence of N-terminal acetylation in 
eukaryotes is undebatable as approximately 85.0% of eukaryotic cellular proteins have 
been shown to be N-terminally acetylated by global analyses (Arnesen et al. 2009; 
Polevoda et al. 2000.; Polevoda et al. 1999). Notably, the modification occurs rarely, if at 
all, in Archaea and Bacteria (Arnesen et al. 2009; Polevoda et al. 2000.; Polevoda et al. 
1999), which is in agreement with the frequency of N-terminally acetylated proteins 
occurring in accordance with organismal complexity (Polevoda et al. 1999; Arnesen et al. 
2009). While  N-terminal acetylation constitutes a complex regulatory system in 
eukaryotes, the physiological consequence of N-terminal acetylation remains to be 
understood. 
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NAT Complexes 
N-terminal acetylation is catalyzed by a collection of enzymes known as N-
terminal acetyltransferases (NATs).  As mentioned previously, NATs catalyze the 
transfer of acetyl functional groups from acetyl-coenzyme A to the a-amino group at the 
N-terminal residues, neutralizing the positive charge of the residue and barring further 
modification of the N-terminus (Kontaxi and Piccardo,  2017; Polevoda et al. 2002).  
While referred to generally as a PTM, N-terminal acetylation occurs co-translationally 
when ³ 20 residues extrude from the ribosome (Kontaxi and Piccardo, 2017; Polevoda et 
al. 2002).Because N-terminal acetylation is not dependent on the identity of a single 
residue,  the N-terminal sequences subject to this modification exhibit high sequence 
diversity. Consequently, attempts to predict the likelihood of N-terminal acetylation on 
the basis N-terminal residue identity are largely ineffective (Helbig et al. 2010). Most of 
the current insights concerning the NAT complex specificity are credited to knockout 
studies performed in yeast. It is now known that NATs exhibit highly characteristic 
substrate specificities that depend on the identity of multiple residues, typically those 
present in the P2 and P3 positions (Singer and Shaw, 2003). Collectively, serine, alanine, 
methionine, glycine, and threonine constitute over 95% of N-terminally acetylated 
residues observed in eukaryotic organisms (Polevoda and Sherman, 2000; Polevola et al. 
1999).  
NATs are part of the GCN5 (general control non-derepressible 5)-related 
acetyltransferase (GNAT) superfamily (Coleman et al. 1996). Characteristic to the GNAT 
superfamily, all NATs contain the conserved motif, Q/RxxGxG/A, which is responsible 
for binding of acetyl-CoA (Coleman et al. 1996). While NATs can exist in monomeric 
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states, they typically function in multimeric complexes that consist of one major subunit, 
which dictates both substrate specificity and catalytic activity, and up to two auxiliary 
subunits, which have varied functions (Liszczak et al. 2013).  
To date, six different NAT complexes (NatA-F) are currently described in 
mammals, though NatA-E are also observed in S. cerevisiae (Arnesen et al. 2009; Forte 
et al. 2011). Approximately 50% of the yeast proteome is proposed to be N-terminally 
acetylated by the collective action of NatA, NatB, and NatC, along with their respective 
catalytic subunits, Ard1, Nat3, and Mak3 (Pezza, et al. 2009; Arnesen et al. 2009; Aksnes  
et al. 2015; Gautschi et al. 2003; Singer and Shaw, 2003).  
In terms of substrate specificity, NatA acetylates alanine, glycine, threonine, and 
serine residues exposed by methionine cleavage (Gautschi et al. 2003; Arnold, et al. 
1999), while NatB targets methionine residues for acetylation when they are followed by 
either alanine, glutamine, asparagine, or methionine at the P2 position (Forte et al. 2011; 
Polevoda et al. 2003). While thought to be influenced by other sequence elements, NatC 
acetylates methionine residues adjacent to either isoleucine, leucine, tryptophan, or 
phenylalanine at P2 (Forte et al. 2011; Polevoda, 2001).  Of the NAT complexes,  NatD 
appears to be more specialized, catalyzing the N-terminal acetylation of histones, while 
NatE only acetylates substrates with leucine at P3 and proline at P4 (Forte et al. 2011). 
 
NatA 
NatA is comprised of two main subunits: its adaptor subunit, Nat1, and its 
catalytic subunit, Ard1, a GNAT homologue which recognizes a wide range sequences, 
allowing for a diverse collection of appropriate substrates. (Eiyama et al. 2015; Gautschi 
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et al. 2003) The genes encoding  the respective NatA subunits were first suggested by 
nat1- and ard1- mutants, which lacked NAT activity and exhibited the similar pleiotropic 
phenotypes of slow growth, temperature sensitivity, failure to enter G0, and failure to 
sporulate (Mullen et al. 1989). In the same study, the co-linear functionality of Nat1 and 
Ard1 was further emphasized through a 20-fold increase in NAT activity, reported only 
when both genes were overexpressed (Mullen et al. 1989). Subsequent studies have since 
confirmed that both NatA subunits are essential for activity, as single mutants were 
unable to execute N-terminal acetylation of characteristic substrates in vivo (Mullen et al. 
1989; Polevoda et al. 1999; Arnesen et al. 2005). It is proposed that a third subunit, Nat5, 
may also be present in NatA complexes. While the function of Nat5 is unknown, single 
deletion mutants for either Ard1 or Nat5 exhibited nearly identical phenotypes, exhibiting 
slow growth, temperature and salt sensitivity, and osmotic sensitivity, among others 
(Geissenhoner et al. 2004). 
Nat1, the non-catalytic NatA subunit, mediates the stable interaction of the NatA 
complex with the large ribosomal unit and promotes association with nascent 
polypeptides of approximately 50 to 80 amino acids in length (Gautshi et al. 2003). 
Tetratricopeptide repeat (TPR) motifs within Nat1 likely mediate this interaction (Gautshi 
et al. 2003; Blatch, G.L., Lassle, M. 1999), guiding the nascent polypeptide to the 
catalytic subunit, Ard1, and the functionally undefined subunit, Nat5, allowing for N-
terminal acetylation to occur (Gautshi et al. 2004; Geissenhoner, et al. 2004). 
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NatB  
NatB is composed of one catalytic and one auxiliary subunit, requiring both 
subunits for it activity (Van Damme et al. 2012; Polevoda et al. 2003; Ametzazurra et al. 
2008). Nat3, the 22-kDa catalytic subunit of NatB, was first identified by DNA sequence 
alignment, wherein it was determined that while sequence similarity to other Nat subunits 
was limited overall, Nat3 contained several motifs that of high sequence similarity 
(Polevoda et al. 1999; Coleman et al. 1996).  Most notably, residues 144-149 of Nat3  
resembled the acetyl-CoA binding motif of the GNAT superfamily, Q/RxxGxG/A, 
allowing for the function of the subunit to be deduced and later confirmed (Polevoda et 
al. 1999; Coleman et al. 1996). 
 In contrast, the 93-kDa subunit, Mdm20, exhibits no homology to previously 
characterized proteins (Hermann, et al. 1997). Mdm20 was initially identified as a protein 
essential for tropomyosin-F-actin interaction, though it was later determined that Mdm20 
complexes Nat3 to acetylate substrates, including tropomyosin 1 (Tmp1p) (Caesar et al. 
2005). While both subunits are required for NatB activity, subsequent work demonstrated 
that single knockout strains for each subunit displayed many distinctive phenotypes 
relating to stress resilience and when challenged to grow under minimal media (Caesar et 
al. 2005). NatB may play regulatory role in the cell cycle, as bioinformatic analyses 
revealed a notable overrepresentation of proteins involved in cell cycle regulation and 
DNA processing among NatB substrates (Caesar et al. 2005). Notably, such an 
observation was not made for NatA or NatC knockouts, which failed to display 
significant phenotypic differences upon knockout of functional subunits (Caesar et al. 
2005).  
 24 
 
NatC 
NatC is responsible acetylates of polypeptides with Met-Ile, Met-Leu, Met-Trp, 
and Met-Phe N-termini, although other sequence elements are thought to influence 
processing as well (Polevoda et al. 2001; Forte et al. 2011). In contrast to other NAT 
complexes, not much is known about the NatC complex or its targets (Wenzlau et al. 
2006). NatC acetyltransferases contain three subunits: the catalytic subunit, Mak3, and 
auxiliary subunits, Mak10 and Mak31 (Polevoda et al. 2001). All three subunits are 
required for catalytic activity, as the deletion of any subunits results in abnormal, 
pleiotropic phenotypes, including the inability to acetylate NatC substrates in vivo, and  
diminished growth under stress conditions or while in minimal media (Polevoda et al. 
2001). 
 
Implications of N-Terminal Acetylation 
Overall, N-terminal acetylation is thought to be important to many cellular and 
molecular processes, but its definitive purpose is debated (Van Damme et al. 2011; Lee et 
al. 1989). Most often, N-terminal acetylation is associated with its role in the N-end rule 
pathway and ubiquitin-mediated proteolysis (Persson et al. 1985; Hershko et al. 1984; 
Hwand et al. 2010).  
The N-end rule pathway regulates the half-life of a protein by the specific 
targeting of degradation signals, N-degrons, which promotes polyubiquitination and 
subsequent degradation of the targeted protein (Shemorry et al. 2013; Varshavsky, A. 
2011; Kim et al. 2014). Together, the complimentary nature of N-end rule pathway and 
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ubiquitin-mediated proteolysis enables the degradation of a majority of cellular 
polypeptides, which in turn mediates a legion of physiological functions (Varshavsky, A., 
2011).  
In addition to mediating protein degradation, N-terminal acetylation also holds 
key roles within cellular differentiation, viability, metabolism and proliferation, protein 
translocation, membrane attachment, and protein complex formation (Van Damme et al. 
2014). Unsurprisingly, because of its wide involvement in many processes, the 
phenotypic and physiological effects of N-terminal acetylation are highly varied, 
seemingly dependent on multiple variables, including the protein affected, the NAT 
complex responsible for acetylation, and the organism in which the process occurs. As 
mentioned previously, reduced N-terminal acetylation due to knockout of certain NAT 
complexes lead to fragile growth phenotypes but general viability in yeast. Such a result 
suggests that N-terminal acetylation is important to maintaining function in only some 
proteins; however, the consequence of organismal complexity must be considered. 
 Notably, disturbances in N-terminal acetylation often resulting in the onset of 
potentially lethal diseases in humans.  For example, N-terminal acetylation has a 
suggested  role in the onset of  neurodegenerative disease. a- synuclein is a primarily 
neuronal protein that is known to assemble into amyloid fibrils, the onset of which 
characterizes the often-lethal Parkinson’s disease (PD) and dementia with Lewy Bodies 
(DLB) (Kang et al. 2012; Anderson et al. 2006).  N-terminal acetylation is known to 
affect the secondary structure of a-synuclein in important functional regions, likely 
attributable the stabilization of helicity by neutralization of charge. N-terminal 
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acetylation of a-synuclein generally results in both short and long-range conformational 
effects accompanied by altered rates of fibril assembly (Kang et al. 2012).  
Ogden’s syndrome, the first human genetic disorder directly linked to a mutation 
in NatA, provides another striking example of N-terminal acetylation in human disease 
(Van Damme et al. 2014). Ogden’s syndrome is an X-linked disorder that manifests 
symptomatically by the appearance of cranial abnormalities, hypotonia, and cardiac 
issues, eventually culminating in infant mortality (Van Damme et al. 2014).  NATs have 
also been implicated as both potential oncoproteins and tumor suppressors, with NAT 
expression being varied in cancerous and non-cancerous tissues (Kalvik et al. 2013). 
Furthermore, manipulated NAT expression in cancer cells resulted in apoptosis, 
autophagy or even cell-cycle arrest (Kalvik et al. 2013). 
The purpose of N-terminal acetylation in cells continues to be enigmatic due to 
the variety of effects resultant of this modification. However, its evolutionary importance 
is clear due to its appearance prevalence in eukaryotes. Move over, due to its known 
regulatory roles in cellular processes and implied roles in disease, it is of great 
importance to continue to define the downstream N-terminal acetylation as it may 
improve scientific understanding in these areas.  
 
Purification of Hsp70  
A majority of studies focused on Hsp70s use S. cerevisiae as an expression system 
due to its similarity to higher eukaryotes in protein processing and modification 
(Needham et al. 2015). Among the fourteen Hsp70 homologs expressed in yeast, the 
cytoplasmic Ssa (Stress seventy A) proteins, comprised of Ssa1-4, are the most well-
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studied (Needham et al. 2015; Shaner et al. 2005). The Ssa subfamily is the only 
cytosolic subfamily of Hsp70s that is essential (Needham et al. 2015; Shaner et al. 2005; 
Wegele et al. 2003b ). While all Ssa proteins are expressed differentially, at least one of 
the possible four Ssas must be expressed for cell viability (Shaner et al. 2005; Wegele et 
al. 2003b). Of the other Ssa chaperones, Ssa1 is of particular interest due to its dynamic 
gene expression under varied physiological conditions and its roles in proteostasis and 
prion propagation (Needham et al. 2015; Shaner et al. 2005; Wegele et al. 2003b).   
Current studies of Ssa1 prove limited due to the capacities and intentions of current 
purification methods. While several methods exist, they are fairly similar in approach, 
and are often both resource intensive and time-consuming. To demonstrate this point, the 
details common to Ssa1 purification methods that are used within the field will be briefly 
summarized. 
The majority of Ssa1 purifications require a high initial cell density prior to lysis, as 
most protocols require cell density measurements to approximate 10 ODs to achieve 
sufficient chaperone yield (Cyr et al. 1992, Needham et al.2003). One method calls for a 
starting OD of 2.5, though in this method, Ssa1 is expressed in Pichia pastoris rather than 
its endogenous yeast. P. pastoris is a notable eukaryotic expression system because it can 
achieve gram amounts of recombinant protein per liter of culture by secretory and 
intracellular means (Ahmad et al.2014; Wegele et al. 2003.) Noting this exception, 2-6 
liters of starting cell culture is typical for methods using S. cerevisiae, emphasizing the 
need for high starting cell densities to obtain a reasonable yield (Cyr et al. 1992). 
Often cells are lysed via glass bead lysis (Cyr et al. 1992; Needham et al. 2003; 
Wengele et al. 2003), followed and several rounds chromatography. A combination of 
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affinity chromatography and ion-exchange chromatography is commonly used to obtain 
Ssa1 fractions from cell lysates (Cyr et al. 1992; Needham et al. 2003). By utilizing both 
ion-exchange column chromatography, which separates ionizable molecules based on 
their total charge (GE Healthcare, 2018), and affinity chromatography, a technique which 
utilizes the specific interaction between an immobilized ligand and the protein of interest 
to isolate the desired protein from its surrounding mixture (GE Healthcare, 2016), it is 
relatively ensured that pure Ssa1 protein will be isolated.  
If not immediately precipitated (Wengele et al. 2003),  chaperone fractions are 
combined, dialyzed, concentrated, and subjected additional rounds of chromatography in 
order to ensure purity of the sample (Cyr et al. 1992; Needham et al. 2003; Wengele et al. 
2003). Some methods will alternate different chromatographic approaches to enhance 
purity and yield, as exemplified by one method which used hydrophobic interaction 
chromatography, a technique that separates based on hydrophobicity (GE Healthcare, 
2018) followed by size exclusion chromatography, which separates molecules based on 
molecular size (GE Healthcare, 2018c; Wengele et al. 2003).  
Protein purity was seldom reported, though one method stated that Ssa1 preparations 
were 98% pure (Cyr et al. 1992). Chaperone yields reported varied between methods, 
though several yields were within the milligram range, indicating reasonable purification 
efficiency (Needham et al. 2003; Wengele et al. 2003).  Notably, only one method 
utilized an affinity tag, namely a His tag, to purify Ssa1 by affinity chromatography 
(Aron et al. 2005). While this method was efficient and obtained a reasonable yield, its 
use of an affinity-tag emphasized its novelty when compared to other purification 
schemes for Ssa1. 
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From parsing protocols used in the field, it is clear that Ssa1 purifications are 
generally demanding in terms of resources, time, and experience. Most methods are 
large-scale, multistep, and produce similar chaperone yields and purity. Whiles such 
methods suit their general purpose, they are generally exclusionary to smaller institutions 
that lack the necessary resources.  
Realizing this opportunity, we developed a highly efficient, one-step purification 
method that is both user-friendly and affordable. By using a Ssa1-Protein-A fusion strain 
in combination with IgG-conjugated magnetic beads, our method facilitates purification 
by the high-affinity interaction between the Protein-A tagged Ssa1 and IgG-conjugated 
magnetic beads. Using this purification method, we avoid using expensive of 
chromatography columns in lieu of magnetic Dynabeads, which are more affordable, and 
can be conjugated to IgG in house.  We have eliminated the need for large starting culture 
volumes as this method obtains high yields of Ssa1 from a starting OD of 5, which can 
typically be achieved by 25mL cultures. Notably, the yields that are achieved by this 
purification are in a 3-fold increase compared to those reported by similar methods 
(Griffith et al. 2018). Furthermore, our method is compatible with native elution, yielding 
enzymatically active chaperone (Griffith et al. 2018), allowing for the future study of 
Ssa1 in the context of N-terminal acetylation. 
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Materials and Methods  
Cell culture 
Yeast were grown in standard rich media YPD in either a roller drum or shaking 
incubator at 30°C and harvested at mid-to late-exponential phase as determined by optical 
density (OD600). E. coli were grown in standard LB in either a roller drum or shaking 
incubator at 37°C and harvested when OD600 ³ 0.5.  
 
SDS-PAGE and Western blotting 
Samples were resolved on a polyacrylamide gel and stained with Coomassie BB R-250 
(Thermo Fisher) or transferred to a PVDF membrane for Western blot analysis. Anti-
Ssa1/2 (Invitrogen), anti-Gpd1 (Thermo Fisher), anti-GAPDH (Thermo Fisher), and anti-
Ydj1 (Thermo Fisher) were used to probe resolved proteins, with Goat-anti-rabbit HRP 
(Thermo Fisher) used as a secondary antibody. Proteins were visualized by ECL (Thermo 
Scientific) and imaged using a ChemiDoc XRS+ imaging system (Bio-Rad).   
 
Ssa1-PrA Purification  
Cultures were grown in YPD liquid media and were continually diluted to maintain 
exponential phase growth for 24 hours before lysis. 15 OD of exponentially growing 
culture were pelleted and washed with cold distilled water. Cells were pelleted in a 
2.0mL flat bottom microcentrifuge tube at 13,000 rpm for 5 minutes at 4°C. Cells were 
then resuspended in cold lysis buffer (20mM Tris-HCl (pH 8.0), 150mM NaCl, 10mM 
MgCl2, 2mM PMSF, protease inhibitor tablet (Thermo Fisher Scientific), and 1mM 
EDTA). Glass beads were then added to a total volume of 1mL and vortexed for 7 
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minutes at 4°C. Cell lysates were separated from glass beads and mixed with 10x 
detergent (20mM Tris-HCl (pH 8.0), 150mM NaCl, 10mM MgCl2, 1% NP-40, and 
0.25% Na-deoxycholate). 
500µL of lysate-detergent mix was introduced to 50µL of IgG conjugated magnetic 
Dynabeads and allowed to nutate at 4°C for at least 1.5 hours. The supernatant was 
removed, and magnetic beads were washed once in wash buffer (20mM Tris (pH 8.0), 
150mM NaCl, 10mM MgCl2, 1% NP-40, 0.25% Na-deoxycholate) at 4°C and three times 
at room temperature. Magnetic beads were washed once with 1mL of 50mM Tris-HCl 
(pH 7.0) at room temperature. Proteins were prepared for SDS-PAGE by either heating 
for 10 minutes at 70°C in non-reducing SDS buffer (150mM Tris-HCl pH 6.8, 30% 
glycerol, 6% SDS, 0.03% bromophenol blue) to detect any non-covalently associated 
proteins or boiled for 3 minutes in SDS-PAGE sample buffer for total protein detection.  
 
Native Elution of Ssa1  
Ssa1 was eluted under native conditions by incubating washed magnetic beads with 30µL 
of elution buffer (0.1M sodium acetate pH 3.5), followed by immediate neutralization by 
the addition of 3µL of 1.5M Tris (pH 8.8). Native Ssa1 elution was achieved by 
incubating washed magnetic beads with a 1:300 dilution of PreScission Protease (PPX, 
GE Healthcare) for 16 hours at 10°C.  
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Proteinase K digestion 
Eluted Ssa1 protein was concentrated using a Micron YM-30 centrifugal filter and 
reservoir (Millipore) at 14000 x g for 14 minutes at 4°C. A buffer exchange was 
performed the concentrated protein by adding 25µL of cold Proteinase K assay buffer 
(25mM Tris pH 7.4, 50mM KCl, 5mM MgCl2) and repeating centrifugation under the 
previous specifications. The concentrated protein was resuspended in 22.4µL of 
Proteinase K assay buffer and transferred into a new reservoir. 2.5µL of 50mM ATP was 
then added and the mixture remained at room temperature for 20 minutes. An 8µL 
sample was taken before addition of the Proteinase K as a negative control. 1µL of 1:100 
Proteinase K was added to the mixture. 8µL samples were taken at 5 and 15 minutes, 
respectively. All samples were introduced to an equal volume of 40% T.C.A. and 
remained at 4°C for 30 minutes after completion of the digestion reaction. Samples were 
centrifuged at 13.3 x 103 min-1 at 2°C for 20 minutes. Pelleted protein was then washed 
with 500µL of cold 100% acetone and resuspended in SDS-PAGE sample buffer.  
 
Isoelectric Focusing of Ssa1-PrA 
55µL of 10x detergent was added yeast cell lysates. Lysates were then mixed with IEF 
sample buffer (Bio-Rad) in a 1:5 proportion and remained on ice until gel loading. 
Lysates were resolved on a Criterion IEF Pre-Cast gel pH 3-10 (Bio-Rad) on a Criterion 
cell (Bio-Rad) as per manufacturer’s instructions. The IEF gel was protonated in 0.1% 
acetic acid mixture for 5 minutes, followed by submersion in distilled water for 1 minute. 
Resolved proteins were transferred to a PVDF membrane using a Trans-Blot Turbo 
Blotting System (Bio-Rad) and were probed by Western blot.  
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Cross-linking of Ssa1 and associated proteins  
Duplicate cultures were grown in YPD liquid media and were continually diluted to 
maintain exponential phase growth for 24h before lysis. 15 OD equivalents were pelleted 
and washed twice with reaction buffer (1M HEPES pH 7.5) before resuspension in 
reaction buffer. 75µL crosslinker solution (20mM DSP (Thermo Fisher) in dry DSMO) 
was added to reach a final concentration of 1.5mM of the crosslinker solution. The 
reaction mixture remained at room temperature for 30 minutes. Stop solution (1M Tris 
pH 7.5) was then added to the reaction mixture to a final concentration of 15mM, 
remaining at  room temperature for 15 minutes. After 15 minutes, cells were pelleted and 
washed three times with cold lysis buffer. Cells were lysed by glass bead lysis and Ssa1-
PrA and any  associated proteins were co-purified from cell lysates as previously 
specified.  
 
Transformation of Ydj1 plasmid 
1µL of purified Ydj1 plasmid was added to 50µL of DE3 competent cells and the mixture 
sat on ice for 30 minutes. Cells were heat-shocked for 3 minutes at 37°C and immediately 
transferred back to ice. Cells remained on ice for  at least 2 minutes, after which, 250µL 
of LB was added to the cells and allowed to grow in a roller drum at 37°C for 20 minutes. 
75µL of transformed cells were then plated onto a solid LB +amp plate and sat for 1 
minute at room temperature before the plates were inverted and incubated for 12 hours at 
37°C.  
 
 34 
Purification of Ydj1 
Transformed cells were grown in LB+amp liquid media and continually diluted to 
maintain exponential phase growth for 24 hours. Before lysis, cells were transferred to 
500mL of fresh LB+amp followed by induction with IPTG for 3 hours under standard 
growth conditions. Induced cells were pelleted, resuspended in 50mL lysis buffer (50mM 
Tris pH 9.0, 50mM NaCl, 1 protease tablet; 50µM PMSF), and lysed by sonication. Cell 
lysates were pelleted at 15000 RPM for 30 minutes at 4°C. Ydj1 was purified using a 
5mL HisTrapFF nickel Sepharose affinity column on a fast protein liquid 
chromatography (FPLC) ÄKTA system, both obtained from GE Lifesciences. The 
column was initially washed before sample injection with Buffer A (50mM Tris pH 9.0; 
150mM NaCl) (flow rate: 3.0mL/min). 41mL of cell lysates were then loaded onto the 
column (flow rate: 2.0mL/min). Column bound proteins were washed with 10 column 
volumes of Buffer A and followed by elution with 4 column volumes of Buffer B (50mM 
Tris pH 9.0; 150mM NaCl; 250mM imidazole). 1mL fractions were collected manually 
during each phase of the purification with the exception of the elution, wherein a 5mL 
fraction was collected during the corresponding mAU peak that indicated the elution of 
column bound Ydj1. All chromatographic data and the execution of the purification 
protocol was administered and recorded by Unicorn start software version 1.1. 15µL 
samples were obtained from the respective collected fractions and were then mixed with 
SDS-PAGE sample buffer. 
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Results  
To understand the effects of N-terminal acetylation on Ssa1 chaperone function, 
we needed to develop a specific pull-down protocol of Ssa1 without disrupting any 
modification of the N-terminus.  To accomplish this goal, a Ssa1-PrA fusion construct 
was transformed into both wild-type (WT) and N-terminal acetylation-deficient 
backgrounds, (Dard1 and S2P, respectively). The Ssa1-PrA fusion construct features a 
Protein-A affinity tag at the extreme C-terminus of Ssa1. Because of the naturally 
occurring affinity between IgG and Protein A, the Protein-A tag allows for pull-down of 
the tagged chaperone when used in combination with magnetic Dynabeads conjugated 
with rabbit IgG. The Ssa-PrA fusion construct additionally encodes a precision protease 
cut site located upstream of the C-terminal affinity tag, allowing for specific proteolytic 
cleavage of the affinity tag from the chaperone when desired.  
WT Ssa1 is known to be N-terminally acetylated, though is expected that the 
chaperone will not be N-terminally acetylated by the NatA when expressed in either the 
Dard1 or S2P backgrounds. In Dard1 background, the NatA complex lacks its catalytic 
subunit, blocking the N-terminal acetylation for all targets of NatA, including Ssa1. In the 
S2P strain, the serine residue at the second position of Ssa1 within the N-terminus is 
changed to proline, specifically blocks N-terminal acetylation of Ssa1 via the XPX rule. 
Expression of the Ssa1-PrA fusion construct in these three genetic backgrounds 
respectively allows for comparison-based chaperone activity studies in the context of N-
terminal acetylation. 
The expression of our fusion protein in WT and N-terminal acetylation-deficient 
genetic backgrounds was previously confirmed. To quantify Ssa1-PrA expression, the 
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total protein content of cell lysates was resolved by SDS-PAGE. Cell lysates were probed 
with an Hsp70-specific antibody to ensure the specificity of the Protein-A fusion, while a 
GAPDH-specific antibody established the load control. Because Protein-A is bound 
specifically by antibodies containing an IgG-heavy chain, Protein-A is recognized by 
goat anti-rabbit HRP, allowing for visualization of the Ssa1-PrA fusion protein; therefore, 
both Ssa1 and Protein-A were visualized by immunoblot (Figure 1). Ssa1-PrA was 
expressed consistently in all three of the evaluated genetic backgrounds. Parent-strains 
produced a single band by Western blot, while transformed strains produced two bands. 
The band present at the higher molecular weight represents the Ssa1-PrA fusion protein, 
which has a higher molecular weight than endogenous Ssa1 due to its Protein-A affinity 
tag; while the band present at the lower molecular weight is endogenously expressed 
Ssa2.  
After confirming expression, we next developed a protocol that would purify 
Ssa1-PrA from WT cell lysates. Therefore, we adapted a purification method that used 
magnetic Dynabeads conjugated with rabbit IgG to facilitate Ssa1-PrA pull-down the 
naturally high-affinity interaction between Protein-A and IgG.  Ssa1-PrA pull-down was 
highly specific, as non-specific proteins were not observed with colloidal Coomassie 
Blue stain (Figure 2). A single band of approximately 55-kDa was observed, though this 
band is the heavy chain of the rabbit IgG and is expected under the denaturing conditions 
of the SDS-load buffer (Figure 2, lanes 5 and 6). Silver stain confirmed the specificity of 
Ssa1-PrA pull-down as non-specific proteins were not observed (Figure 3). 
Immunoprecipitants from WT, Dard1, and S2P strains resolved by gel electrophoresis 
indicated that Ssa1-PrA pull-down was consistent for all generated strains (Figure 4).  
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While Ssa1-PrA immunoprecipitants were highly pure, we next wanted to assess 
the quantity of chaperone that was obtained via our pull-down method. Ssa1-PrA 
immunoprecipitants obtained from a 5 OD equivalent of WT cells were resolved by SDS-
PAGE alongside a BSA titration, ranging from 10 to 25µg (Figure 5). The band intensity 
corresponding to the immunoprecipitated Ssa1-PrA was intermediate to that of the 10 and 
25µg BSA, suggesting that approximately 15µg of Ssa1-PrA can be obtained from 5mL 
of exponentially growing culture as starting material.  
Though Ssa1-PrA pull-down was both highly specific and efficient,  the Ssa1 
chaperone network is diverse and subject to interaction of Ssa1 with a wide variety of co-
chaperones, nucleotide-exchange factors, and client proteins; all of which modulate 
chaperone activity. In addition to these factors, both x-ray crystallographic analyses 
(Wilbanks and McKay, 1995) and kinetic assays (Feifel et al. 1999) indicated that 
monovalent ion identity dramatically influences enzymatic activity by stabilizing the N-
terminal nucleotide binding cleft. From these studies, it was determined K+ promoted 
maximal ATPase activity and client binding, while Na+ induced minimal levels of these 
activities (Feifel et al. 1999); therefore, we next assessed if our method could co-purify 
Ssa1 in complex with one of clients by repeating Ssa1-PrA pull-down under low and high 
salt concentrations (150mM and 300mM, respectively) and with NaCl substituted for 
KCl. While we did not observe confirmed pull-down of Ssa1 clients, different amounts of 
Ssa1-PrA were pulled-down under each condition (Figure 6), demonstrating that pull-
down is robust under altered experimental conditions. These data suggest that our method 
may have an alternative use in the quick optimization of pull-down conditions necessary 
for downstream analyses.  
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Though pull-down was highly specific, efficient, and robust, the removal of Ssa1-
PrA from magnetic beads was achieved under denaturing conditions. Denaturing 
conditions inactivate the chaperone, rendering it unsuitable for downstream analyses 
requiring enzymatic activity. The dissociation of IgG bound to Protein-A Sepharose 
columns can be achieved using an elution buffer with a pH of 3.5 (Duhamel et al. 1979); 
therefore, we repeated the immunoprecipitation of Ssa1-PrA to determine whether a 
similar pH shift could elute our fusion protein from our magnetic beads sufficiently. 
Proteins were eluted with 0.1M sodium acetate buffer (pH 3.5) followed by subsequent 
neutralization of eluates with 1.5M Tris buffer (pH 8.8). Ssa1-PrA was found to elute 
under these conditions, though a portion of the fusion protein remained associated with 
the beads post-elution (Figure 7). Nevertheless, using the pH shift acted sufficiently as a 
native elution technique for Ssa1-PrA, preserving both native chaperone structure and 
ensuring compatibility with downstream assays.  
Using the pH shift as a native elution technique allowed for timely elution of 
Ssa1-PrA from the IgG-conjugated magnetic Dynabeads, though it did not address the C-
terminal Protein-A affinity tag, the presence of which may inherently hinder structural 
characterization of natively isolated chaperone. The Ssa1-PrA construct was designed to 
include a PreScission protease (PPX) cut-site upstream of the C-terminal Protein-A 
affinity tag. PreScission protease is highly specific, cleaving between Gln and Gly 
residues of its recognition sequence LeuGluValLeuPheGln/GlyPro, resulting in a reduced 
likelihood of off-target proteolysis. Digestion of Ssa1-PrA by PreScission protease results 
in the removal of the Protein-A tag and the native elution of Ssa1 (Figure 8a). Ssa1 
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elution appears to be complete with no uncut fusion protein associated with the magnetic 
beads, as only IgG and Protein-A are visible by colloidal Coomassie stain (Figure 8b).  
 Eluting Ssa1-PrA by PreScission protease yielded highly pure Ssa1 chaperone 
under native conditions. Presumably, removal of the Protein-A affinity tag yields 
chaperone that was structurally comparable to endogenously expressed Ssa1. It was 
reported that partial proteinase K digestion of Ssa1 in the presence of ATP produces a 
distinct 45-kDa fragment, indicative of N-terminal nucleotide-binding domain (NBD), as 
well as a transient fragment of approximately 60-kDa, representing the protected C-
terminal substrate-binding domain (SBD) in the ATP-bound state (Needham and Masison 
2008). To determine whether characteristic features of Ssa1 structure could be observed, 
we attempted a partial Proteinase K digestion of our eluted Ssa1 protein (Figure 9). 
Before the introduction of Proteinase K, two distinct bands were observed at 75- and 45-
kDa, indicative of our undigested chaperone and the N-terminal NBD, respectively. A 
third band was also observed at 60-kDa, which is consistent with the C-terminal SBD. At 
five minutes after the introduction of the Proteinase K, the 75-kDa band was no longer 
visible. Furthermore, the 60-kDa band becomes highly faint by this time-point. The 60-
kDa band completely disappears by fifteen minutes, leaving only the 45-kDa band 
present by the end of the observation period. These data suggest that eluted Ssa1 is 
structurally comparable to endogenous chaperone. 
  While it is predicted that N-terminal acetylation is necessary for proper Ssa1 
function, both non-N-terminally acetylated and N-terminally acetylated chaperone are 
required to fully elucidate the effect of this modification on chaperone activity via 
comparative analyses. We next focused on confirming the expected N-terminal 
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acetylation status of Ssa1 in our established genetic backgrounds by isoelectric focusing 
(IEF). IEF is an electrophoretic procedure wherein zwitterionic molecules are separated 
by isoelectric point (pI), the pH wherein the net charge of the resolved molecule is zero 
(Brasher and Thorpe, 1998).  pI values are known to change when target proteins are 
modified, resulting in a discernable change in protein migration between the modified 
and unmodified forms. There is a visible migratory shift between WT Ssa1-PrA and 
Dard1 Ssa1-PrA when resolved by IEF and probed by Western blot with Ssa1/2 specific 
antibody. The band for WT Ssa1-PrA runs more acidic than Dard1 Ssa1-PrA, indicating 
the N-terminal acetylation of WT Ssa1-PrA and the absence of this modification in the 
Dard1 background (Figure 10).  
There are various mechanisms by which N-terminal acetylation may alter Ssa1 
activity; however, altering the association of Hsp70 co-chaperones is a likely mechanism 
which would stand to affect several downstream processes due to the expansiveness of 
the Hsp70 chaperone system.  By reconstituting components of the Hsp70 chaperone 
system in vitro, it is possible to use a comparative approach to assess whether N-terminal 
acetylation alters co-chaperone binding, and therefore, Ssa1 activity. We began our effort 
to reconstitute the Hsp70 chaperone system by attempting to co-purify Ssa1-PrA with 
endogenous Hsp40, a major co-chaperone family to Hsp70. To co-purify Hsp40, we 
intracellularly crosslinked Ssa1-PrA with endogenous co-chaperone with DSP prior to 
purification. Coomassie stain revealed that Ssa1-PrA failed to facilitate pull-down of 
endogenous Hsp40 or other co-chaperones involved in the Hsp70 chaperone system 
(Figure 11).  
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 The inability to co-purify endogenous co-chaperones by crosslinking suggests that 
the purification of Hsp40 would likely have to occur separately from that of Ssa1 to allow 
for future studies requiring the co-chaperone to evaluate in Ssa1 activity in the context of 
N-terminal acetylation.  We first expressed an Hsp40 co-chaperone of Hsp70, Ydj1, in 
competent E. Coli DE3 cells.  While the Hsp40 is endogenously expressed in S. 
cerevisiae, expressing Ydj1 in a prokaryotic system blocks post-translational 
modification, preventing downstream changes in Ssa1 activity that may be attributable to 
the modification of Ydj1 rather than changes in Hsp70 N-terminal acetylation. DE3 cells 
were transformed with an expression plasmid containing His-tagged Ydj1 under an 
IPTG-inducible promoter. Cell lysates from uninduced cultures and those induced with 
IPTG were resolved by SDS-PAGE and probed by Western blot using Ydj1-specific 
antibody, which revealed that induced cells expressed His-tagged Ydj1 (Figure 12).  
 Once the expression of His-tagged Ydj1 was confirmed, we then purified Ydj1 for 
use in binding assays. Using immobilized metal affinity chromatography (IMAC), it is 
possible to use the affinity between the histidine tag and the nickel Sepharose 
immobilized within a fast protein liquid chromatography (FPLC) HisTrapFF column (GE 
Lifesciences) to isolate our protein of interest from cell lysates. Protein concentration is 
measured by absorbance at 205nm as a function of flow through the nickel Sepharose 
column, producing the chromatograph in Figure 13a. The total protein content of the cell 
lysates (FT: 0-45mL) were run through the column, washed, and the elution of His-
tagged Ydj1 from the column is indicated by the peak in mAU absorbance at 100mL. 
When proteins from purification fractions were resolved by SDS-PAGE, pull-down of 
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His-tagged Ydj1 appears to be relatively specific as few contaminating bands were 
present within the elution fraction, as indicated by Coomassie Blue stain (Figure 13b). 
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Figure 1. Protein-A fusion Ssa1 chaperone (Ssa1-PrA) is expressed in both WT and 
N-terminal acetylation deficient backgrounds, allowing for purification and future 
comparative analyses. Lysates from wild-type (WT) and N-terminal acetylation 
deficient (△ard1, S2P) backgrounds were resolved by SDS-PAGE, transferred to PVDF 
membrane, and probed for Ssa1/2. Membrane was re-probed for GAPDH as a load 
control.  
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Figure 2. IgG-conjugated magnetic beads facilitate pull-down of Ssa1-PrA from cell 
lysates. (FT) Lysates nutated end-over-end with IgG-conjugated magnetic Dynabeads for 
1.5 hours at 4°C. (IP) Beads were boiled with SDS. Proteins were separated by SDS-
PAGE and stained with Coomassie Blue dye. 
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Figure 4. Quantification of purified Protein A-tagged Ssa1 by BSA titration indicates 
that method is highly efficient, yielding 15 ug per 5 OD equivalent. (IP) Beads were 
heated in LDS to interrupt non-covalent interactions. Proteins non-covalently associated 
with beads were boiled in SDS. Proteins were separated by SDS-PAGE and stained with 
Coomassie Blue dye. *confirmed by Bradford assay (data not shown) 
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Figure 3. Silver stain of Ssa1-PrA pull-down indicates that method is highly specific 
and yields pure chaperone. (IP) Beads were boiled with SDS. Proteins were separated 
by SDS-PAGE and stained with Silver Stain (Pierce) per manufacturer’s instructions. 
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Figure 5.  Ssa1-PrA pull-down is unaffected by altered ionic conditions, indicating 
that method is robust and may prove useful in prototyping experimental conditions. 
To investigate claims on the differential effects of Na+ and K+ on the stability of Hsp70-
polypeptide complexes, Ssa1-PrA pulled -down under different ionic conditions. Salt 
type and concentration are shown. Beads were boiled with SDS. Proteins were separated 
by SDS-PAGE and stained with Coomassie Blue dye. 
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Figure 6. Purification method is compatible with pH shift, facilitating elution of 
Ssa1-PrA under native conditions. IgG-conjugated magnetic Dynabeads with non-
covalently linked Ssa1 were incubated in 0.1M sodium acetate pH 3.5 at 35°C for 16 
minutes. Eluates were neutralized using 1.5M Tris pH 8.8. Post-elution beads are shown. 
Arrows indicate remaining IgG heavy chain (HC), light chain (LC). Proteins were 
separated by SDS-PAGE and stained with Coomassie Blue dye. 
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Figure 7. PrA tag is cleaved from Ssa1 via Pre-Scission protease (PPX) providing a 
second native elution technique that addresses C-terminal PrA tag. The native 
elution of Ssa1 was achieved by using 1:300 dilution of Pre-Scission protease (GE 
Healthcare) at 10°C for ³16 hours. Post-elution beads are shown. Arrows indicate 
remaining IgG heavy chain (HC), light chain (LC), or Protein-A (PrA). Proteins were 
separated by SDS-PAGE and stained with Coomassie Blue dye. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 50 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Partial-digestion of PPX-eluted Ssa1 by Proteinase K indicates 
characteristic Ssa1 structure.  Ssa1 protein was incubated at 25°C with 5 mM ATP for 
20 minutes, and then digested by proteinase K (PrK) for 5 or 15 minutes at 25°C. 
Proteins were separated by SDS-PAGE and stained with Coomassie Blue dye. Arrows 
indicate the positions of reaction products previously characteristic to Ssa1 digestion. 
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Figure 9.  Ssa1-PrA pull-down is consistent across both WT and N-terminal 
acetylation deficient strains (△ard1, S2P), allowing for future comparative analyses. 
(IP) IgG-conjugated magnetic Dynabeads were heated in LDS, interrupting non-covalent 
interactions. Non-covalently associated proteins were boiled in SDS load buffer. Proteins 
were separated by SDS-PAGE and stained with Coomassie Blue dye. 
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Figure 10. Isoelectric focusing of Ssa1-PrA from WT and △ard1 knockout indicates 
that Ssa1 is N-terminally acetylated by the NatA complex. Cell lysates from both WT 
and △ard1 yeast strains expressing Ssa1-PrA were resolved by isoelectric focusing on a 
Criterion IEF Pre-cast gel pH 3-10 (Bio-Rad) per manufacturer’s instructions. Gel was 
protonated in 0.7% acetic acid for 5 minutes and transferred to PVDF membrane. 
Membrane was probed by for GPD1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Failure of Ssa1-PrA to crosslink with endogenous Hsp40 suggests that 
purification of exogenous Hsp40 is necessary to conduct future Hsp70 
characterizations. Intracellular Ssa1-PrA was crosslinked to associated binding partners 
prior to IP using DSP. Lysates nutated end-over-end with IgG-conjugated magnetic 
Dynabeads for 1.5 hours at 4°C. (IP) Beads were boiled with standard SDS load buffer. 
Visualized by SDS-PAGE/Coomassie stain. 
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Figure 12. Ydj1 is expressed in transformed DE3 cells upon induction with IPTG. 
Lysates from uninduced and induced DE3 cells transformed with Ydj1 plasmid were 
resolved by SDS-PAGE, transferred to PVDF membrane, and probed for Ydj1. 
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Figure 13. His-tagged Ydj1 is pulled-down via IMAC. A. (Induced) Cell lysates of 
induced DE3 cells prior to loading onto the HisTrapFF column. (FT) After column 
loading, proteins that did not bind to column were collected. (Wash) Proteins that 
dissociated from column upon wash stage of purification were collected. (Elution) 
Column-bound proteins separated from column. Sample fractions were separated by 
SDS-PAGE and stained with Coomassie Blue. B. Chromatograph corresponding to Ydj1 
purification. Total volume processed by the column during purification is indicated at the 
X-axis. Absorption of mAU values (indicating protein detection at 205 nm) recorded 
during the course of purification is shown at the Y-axis. Stages of purification are 
marked.  
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Discussion 
            In this study, we developed a one-step purification of Ssa1 from S. cerevisiae 
through the collective integration of several purification techniques. This method utilizes 
the high affinity interaction that occurs between Protein-A and IgG to facilitate a highly 
specific pull-down of Ssa1, as indicated by Coomassie Blue stained (Figure 2) and Silver-
stained SDS-PAGE (Figure 3). The use of IgG-conjugated magnetic Dynabeads enhances 
purification efficiency as the beads remain mobile in solution, allowing for maximum 
contact with soluble protein while also exhibiting a low rate of non-specific binding. 
While the IgG can be stripped from the beads during elution, it is possible to re-conjugate 
IgG to the beads after use, minimizing unnecessary cost. Elution by pH shift should not 
affect the conjugation of the IgG to the beads and  if elution is accomplished using 
PreScission protease, the interaction between the Protein-A and IgG can be interrupted by 
pH shift and the IgG-conjugated beads can be separated from the Protein-A tag. 
Additional cost is also avoided as this method is able to purify a significant amount of 
Ssa1 from a limited amount of starting material, as 3.0µg of chaperone is obtained per 
mL of exponentially growing culture, which stands as a significant improvement to yields 
obtained by similar methods (Griffith et al. 2018). In all cases, material cost is reduced.  
   Is it notable that this method yields highly pure chaperone in one-step, 
considering that most proteins require a series of steps to be purified (Labrou N., 2014). 
The ability to purify in one-step is highly desirable in protein purification, as it negates 
costs associated with subsequent purification steps, additional materials and technologies, 
and maximizes time-efficiency. The degree of chaperone purity is maintained under 
native elution conditions (Figure 6, Figure 7), and  while an additional step is required to 
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remove the PreScission protease, it is performed with common reagents due to the 
PreScission protease containing a GST-affinity tag. It should be noted that removal of the 
PreScission protease from purified Ssa1 is unnecessary except in very specific cases due 
to the highly specific action of the enzyme. 
 All data suggests that the Ssa1 obtained this method is representative of its 
endogenous condition, as elution by PreScission protease cleavage did not affect the 
structural integrity of the chaperone, evidenced Proteinase K digestion (Figure 8). A 
potential concern arises in the placement of the Protein-A tag at the extreme C-terminus 
of the chaperone, as this region facilitates interactions with Hsp70 co-chaperones and 
substrates via the C-terminal SBD (Gong et al. 2018). Additionally, the combined effects 
of the location and relative size of the Protein-A tag may impede client and co-chaperone 
interactions, which may explain the failure of our cross-linking attempt (Figure 11). 
However, due to the presence of functionally redundant isoforms of Ssa within the 
cytosol, it is unlikely that such an inability of Ssa1-PrA to engage in typical chaperone 
interactions would pose any detriment to cell viability. 
Arguably, the positioning of the Protein-A tag at the C-terminus is non-
negotiable, as it preserves the structural integrity of the N-terminus and permit its 
modification, as emphasized by the determination that WT Ssa1-PrA is N-terminally 
acetylated by IEF (Figure 10). A potential solution may be to express a new construct that 
extends the linker sequence which connects the extreme C-terminus and the Protein-A 
tag, thereby removing any steric hindrance that is associated with the Protein-A tag, 
allowing for normal chaperone interaction to occur. However, the retained ATPase 
activity of WT Ssa1-PrA after cleavage of its Protein-A tag suggests that the tag does not 
 58 
permanently impair chaperone function (Griffith and Holmes, 2018). While the presence 
of the tag may impede the co-purification of Ssa1-associated proteins, the effect of the 
tag on chaperone activity or binding should be negligible in vitro upon its removal, 
allowing for any observed significant difference to be attributed to differences in N-
terminal acetylation. Nevertheless, the effects of the Protein-A tag on Ssa1 chaperone 
function and binding should be addressed in the future. 
 Because we were unable to co-purify endogenous co-chaperone with Ssa1-PrA in 
S. cerevisiae, we instead expressed and purified the Hsp40 co-chaperone, Ydj1, in an 
exogenous prokaryotic system. The purification of Ydj1 by IMAC was successful and the 
resulting yield was reasonably pure, as determined by SDS-PAGE and the mAU peak 
seen during the corresponding chromatograph, respectively (Figure 13a, Figure 13b). 
While we did not quantify the yield of co-chaperone attained by this purification method, 
the appearance of protein bands following Coomassie staining indicated that our eluted 
protein concentration was within a milligram range. While it is highly unlikely that a 
protein other than Ydj1 would be purified in high concentrations using this approach, we 
did not confirm the identity of our purified protein by Western blot. It still remains 
necessary to assess whether that the His-tag can be cleaved from the purified Ydj1, and 
that the co-chaperone is enzymatically active. These are all necessary steps before 
initiating Ssa1 co-chaperone binding studies. Acknowledging these limitations, the Ydj1 
that is obtained by this purification is arguably sufficient for its intended use in future 
studies.  
 Understanding the various factors which contribute to chaperone function, 
efficiency, and mechanism is of great importance. This importance is only further 
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stressed after assessing the cooperative and dynamic relationships ongoing between the 
major chaperone families and their various co-chaperones in order to maintain 
proteostasis. Of the chaperone families, the need for the continued study of Hsp70 and its 
modification is emphasized when considering the apparent incongruity between the 
number of Hsp70-encoding genes and its numerous functional roles within the cell.  
Prior to this study, the functional role of N-terminal acetylation in the context of 
Hsp70 chaperone activity has largely been overlooked, and previous purification methods 
used to obtain Hsp70 were relatively inaccessible due to their expensive, time-consuming 
and materialistic natures. This study established a highly efficient, one-step purification 
of Ssa1 that yields highly pure, enzymatically active chaperone that can be used to further 
elucidate the effects of N-terminal acetylation. Furthermore, this study has also taken the 
steps to establish the basis for evaluating the differences in Ssa1 chaperone activity that 
are attributable to N-terminal acetylation by purifying Ssa1 in N-terminal acetylation 
deficient backgrounds and confirming that WT Hsp70 is N-terminally acetylated by IEF. 
Through the expression and purification of Ydj1, this study has also provided the 
groundwork for future co-chaperone binding experiments, which will provide further 
insight to the contribution of N-terminal acetylation to Hsp70 chaperone activity and 
efficiency.  
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